Clinical Trials Arena on MSN
FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial
The planned study will enrol six to eight paediatric and adult patients with PSS in the US and Europe.
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...
The FDA has approved zidesamtinib for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer.Zidesamtinib (Jideytro, GSK) is designed to provide highly selective coverage ...
SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...
The FDA just approved a new drug for use in ER+/HER2- metastatic breast cancer, based on a large study led by Fred Hutch's Dr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results